BioSpace News Archive

DeepX Diagnostics Inc. announced that its digital dermatoscope DermoSightTM received clearance from the US Food and Drug Administration for teledermatology screening of suspect skin cancer lesions in the United States.

CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, announced that the Company’s CEO, Ryan Davies, recently spoke with biotech executive Raymond F. Vennare about the importance of university partnerships in advancing medical therapeutics.

Telesis Bio Inc., a leader in automated multi-omic and synthetic biology solutions, announced they will be showcasing their automated workflow solutions for streamlining discovery workflows in antibody and therapeutics development at Antibody Engineering and Therapeutics, Europe in Amsterdam, The Netherlands.

ISA Pharmaceuticals B.V. presented the first clinical data of the combination of ISA101b and Regeneron’s anti-PD-1 Libtayo® at the ASCO annual meeting in Chicago.

CEPI, the Coalition for Epidemic Preparedness Innovations, and aVaxziPen Ltd, a biotech company developing a novel needle-free vaccine delivery platform, have announced a partnership to advance the development of two vaccines candidates using aVaxziPen’s solid dose vaccine-delivery platform, which could help end the need for frozen storage of vaccines, thereby improving equitable access to vaccines.

CN Bio, a leading Organ-on-a-Chip company that designs and manufactures single-and multi-organ microphysiological systems, announced that it has appointed Dr. Samantha Macro as Chief Financial Officer.

Brain–computer interface company Precision Neuroscience Corporation announced that the first-in-human procedures in a pilot clinical study of its neural implant system have been successfully completed.

GenFleet Therapeutics published the latest results from the phase Ib/II study of GFH018 with toripalimab（anti-PD-1 antibody）at the 2023 American Society of Clinical Oncology Meeting in Chicago.

Kallyope, Inc. today announced the appointment of Franz Humer, Ph.D., a distinguished global industry leader in the life sciences, finance, and investment, as the new chair of its board of directors.

Theralase Technologies Inc. is pleased to announce the appointment of new independent director, Kaouthar Lbiati, M.D., M.Sc.